1 |
Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ and Powell MB (2008) Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest 118, 3660-3670
DOI
|
2 |
Oswald F, Liptay S, Adler G and Schmid RM (1998) NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol 18, 2077-2088
DOI
|
3 |
Mungamuri SK, Yang X, Thor AD and Somasundaram K (2006) Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Res 66, 4715-4724
DOI
|
4 |
Zavadil J, Cermak L, Soto-Nieves N and Bottinger EP (2004) Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 23, 1155-1165
DOI
|
5 |
Holt LJ (2012) Regulatory modules: Coupling protein stability to phopshoregulation during cell division. FEBS Lett 586, 2773-2777
DOI
|
6 |
O'Neil J, Grim J, Strack P et al (2007) FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 204, 1813-1824
DOI
|
7 |
Ishitani T, Hirao T, Suzuki M et al (2010) Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complex. Nat Cell Biol 12, 278-285
|
8 |
Weng AP, Ferrando AA, Lee W et al (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269-271
DOI
|
9 |
Ranganathan P, Weaver KL and Capobianco AJ (2011) Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 11, 338-351
DOI
|
10 |
Stylianou S, Clarke RB and Brennan K (2006) Aberrant activation of notch signaling in human breast cancer. Cancer Res 66, 1517-1525
DOI
|
11 |
Ma D, Dong X, Zang S et al (2011) Aberrant expression and clinical correlation of Notch signaling molecules in breast cancer of Chinese population. Asia Pac J Clin Oncol 7, 385-391
DOI
|
12 |
Luo DH, Zhou Q, Hu SK et al (2014) Differential expression of Notch1 intracellular domain and p21 proteins, and their clinical significance in gastric cancer. Oncol Lett 7, 471-478
DOI
|
13 |
Grabher C, von Boehmer H and Look AT (2006) Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 6, 347-359
DOI
|
14 |
Erbilgin Y, Sayitoglu M, Hatirnaz O et al (2010) Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL. Dis Markers 28, 353-360
DOI
|
15 |
Min SH, Lau AW, Lee TH et al (2012) Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase. Mol Cell 46, 771-783
DOI
|
16 |
Sahlgren C, Gustafsson MV, Jin S, Poellinger L and Lendahl U (2008) Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A 105, 6392-6397
DOI
|
17 |
Welcker M and Clurman BE (2008) FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8, 83-93
DOI
|
18 |
Fryer CJ, White JB and Jones KA (2004) Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 16, 509-520
DOI
|
19 |
Li N, Fassl A, Chick J et al (2014) Cyclin C is a haploinsufficient tumour suppressor. Nat Cell Biol 16, 1080-1091
DOI
|
20 |
Espinosa L, Ingles-Esteve J, Aguilera C and Bigas A (2003) Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways. J Biol Chem 278, 32227-32235
DOI
|
21 |
Jin YH, Kim H, Oh M, Ki H and Kim K (2009) Regulation of Notch1/NICD and Hes1 expressions by GSK-3alpha/beta. Mol Cells 27, 15-19
DOI
|
22 |
Foltz DR, Santiago MC, Berechid BE and Nye JS (2002) Glycogen synthase kinase-3beta modulates notch signaling and stability. Curr Biol 12, 1006-1011
DOI
|
23 |
Mo JS, Kim MY, Han SO et al (2007) Integrin-linked kinase controls Notch1 signaling by down-regulation of protein stability through Fbw7 ubiquitin ligase. Mol Cell Biol 27, 5565-5574
DOI
|
24 |
Ranganathan P, Vasquez-Del Carpio R, Kaplan FM et al (2011) Hierarchical phosphorylation within the ankyrin repeat domain defines a phosphoregulatory loop that regulates Notch transcriptional activity. J Biol Chem 286, 28844-28857
DOI
|
25 |
Fernandez-Martinez J, Vela EM, Tora-Ponsioen M, Ocana OH, Nieto MA and Galceran J (2009) Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A. J Cell Sci 122, 1574-1583
DOI
|
26 |
Song J, Park S, Kim M and Shin I (2008) Down-regulation of Notch-dependent transcription by Akt in vitro. FEBS Lett 582, 1693-1699
DOI
|
27 |
Wallberg AE, Pedersen K, Lendahl U and Roeder RG (2002) p300 and PCAF act cooperatively to mediate transcriptional activation from chromatin templates by notch intracellular domains in vitro. Mol Cell Biol 22, 7812-7819
DOI
|
28 |
Fryer CJ, Lamar E, Turbachova I, Kintner C and Jones KA (2002) Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes Dev 16, 1397-1411
DOI
|
29 |
Guo S, Liu M and Gonzalez-Perez RR (2011) Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta 1815, 197-213
|
30 |
Yatim A, Benne C, Sobhian B et al (2012) NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol Cell 48, 445-458
DOI
|
31 |
Zhou S, Fujimuro M, Hsieh JJ et al (2000) SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function. Mol Cell Biol 20, 2400-2410
DOI
|
32 |
Wu G, Lyapina S, Das I et al (2001) SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol Cell Biol 21, 7403-7415
DOI
|
33 |
Itoh M, Kim CH, Palardy G et al (2003) Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev Cell 4, 67-82
DOI
|
34 |
Lai EC, Deblandre GA, Kintner C and Rubin GM (2001) Drosophila neuralized is a ubiquitin ligase that promotes the internalization and degradation of delta. Dev Cell 1, 783-794
DOI
|
35 |
Minella AC and Clurman BE (2005) Mechanisms of tumor suppression by the SCF(Fbw7). Cell Cycle 4, 1356-1359
DOI
|
36 |
Nash P, Tang X, Orlicky S et al (2001) Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414, 514-521
DOI
|
37 |
Jafar-Nejad H, Leonardi J and Fernandez-Valdivia R (2010) Role of glycans and glycosyltransferases in the regulation of Notch signaling. Glycobiology 20, 931-949
DOI
|
38 |
Logeat F, Bessia C, Brou C et al (1998) The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci U S A 95, 8108-8112
DOI
|
39 |
Chillakuri CR, Sheppard D, Lea SM and Handford PA (2012) Notch receptor-ligand binding and activation: insights from molecular studies. Semin Cell Dev Biol 23, 421-428
DOI
|
40 |
Mumm JS, Schroeter EH, Saxena MT et al (2000) A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 5, 197-206
DOI
|
41 |
Schroeter EH, Kisslinger JA and Kopan R (1998) Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382-386
DOI
|
42 |
Krejci A and Bray S (2007) Notch activation stimulates transient and selective binding of Su(H)/CSL to target enhancers. Genes Dev 21, 1322-1327
DOI
|
43 |
McElhinny AS, Li JL and Wu L (2008) Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. Oncogene 27, 5138-5147
DOI
|
44 |
Oswald F, Winkler M, Cao Y et al (2005) RBP-Jkappa/ SHARP recruits CtIP/CtBP corepressors to silence Notch target genes. Mol Cell Biol 25, 10379-10390
DOI
|
45 |
Brou C, Logeat F, Lecourtois M et al (1994) Inhibition of the DNA-binding activity of Drosophila suppressor of hairless and of its human homolog, KBF2/RBP-J kappa, by direct protein-protein interaction with Drosophila hairless. Genes Dev 8, 2491-2503
DOI
|
46 |
Borggrefe T and Oswald F (2009) The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci 66, 1631-1646
DOI
|
47 |
Artavanis-Tsakonas S, Rand MD and Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284, 770-776
DOI
|
48 |
Bolos V, Grego-Bessa J and de la Pompa JL (2007) Notch signaling in development and cancer. Endocr Rev 28, 339-363
DOI
|
49 |
Cordle J, Johnson S, Tay JZ et al (2008) A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition. Nat Struct Mol Biol 15, 849-857
DOI
|
50 |
Allenspach EJ, Maillard I, Aster JC and Pear WS (2002) Notch signaling in cancer. Cancer Biol Ther 1, 466-476
DOI
|
51 |
Andersson ER, Sandberg R and Lendahl U (2011) Notch signaling: simplicity in design, versatility in function. Development 138, 3593-3612
DOI
|
52 |
Lai EC (2002) Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins. EMBO Rep 3, 840-845
DOI
|
53 |
Foltz DR and Nye JS (2001) Hyperphosphorylation and association with RBP of the intracellular domain of Notch1. Biochem Biophys Res Commun 286, 484-492
DOI
|
54 |
Bray SJ (2006) Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7, 678-689
DOI
|
55 |
Fiuza UM and Arias AM (2007) Cell and molecular biology of Notch. J Endocrinol 194, 459-474
DOI
|
56 |
Chiang MY, Xu ML, Histen G et al (2006) Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1. Mol Cell Biol 26, 6261-6271
DOI
|
57 |
Espinoza I and Miele L (2013) Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells. Cancer Lett 341, 41-45
DOI
|
58 |
Marignol L, Rivera-Figueroa K, Lynch T and Hollywood D (2013) Hypoxia, notch signalling, and prostate cancer. Nat Rev Urol 10, 405-413
DOI
|
59 |
Kong D, Banerjee S, Ahmad A et al (2010) Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5, e12445
DOI
|
60 |
Palomero T, Sulis ML, Cortina M et al (2007) Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 13, 1203-1210
DOI
|